TRANS1 Aktie

2,32 EUR -3,4971%

Zu Ihrem Onlinebroker

kaufen verkaufen

TRANS1 Aktienkurs : 08:05 ( 15 Min. verzögert)
2,32 € Letzter Kurs	-3,50% Veränderung	2,40 € Vortag	2,32 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
2,32 - 2,32 Tag	3,57 - 1,07 52 Wochen	0 Tag	0 Ø 52 Wochen	2,32 2.000 Stücke	2,41 2.000 Stücke

TRANS1 Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

24.05.

6 New Spine Device Company Financial Reports

TranS1. TranS1, a Wilmington, NC-based spine device company, reported a 26 percent decrease in revenue for the first quarter of 2012. The...
17.05.

DIARY-US MEETINGS / DAY AHEAD

... May 0:00 TRANS1 at Bank of America Health Conf 17 May 13:00 Altria Group Annual S/holder Meeting 17 May 13:00 AmSurg Corp Annual...

16.05.

20 Orthopedic Device Company Q1 Financial Report Updates

TranS1. TranS1, a Wilmington, NC-based spine device company, reported a 26 percent decrease in revenue for the first quarter of 2012. The...
11.05.

Local business briefs - TranS1 names board chairman

LaViolette has been on TranS1's board since August 2008. WILMINGTON | PharPoint Research Inc., with offices in Wilmington and Research Triangle Park, is one of...
10.05.

TranS1 Inc. Appoints Paul LaViolette Chairman of the Board

The Board of Directors of TranS1 Inc. (Nasdaq:TSON) appointed Paul LaViolette, formerly the company's Lead Director, as Chairman of the Board effective immediately. LaViolette replaces Richard...